tiprankstipranks
Calmare Therapeutics Inc. (CTTC)
OTHER OTC:CTTC
US Market

Calmare Therapeutics (CTTC) Financial Statements

0 Followers

Calmare Therapeutics Financial Overview

Calmare Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Calmare Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 16Sep 16Jun 16Mar 16Dec 15
Income Statement-
Total Revenue$ 383.48K$ 500.60K$ 215.19K$ 69.61K$ 544.13K
Gross Profit$ 265.90K$ 374.88K$ 165.65K$ 45.16K$ 372.51K
EBIT$ -913.09K$ -254.53K$ -641.46K$ -585.35K$ -546.39K
EBITDA$ -908.96K$ -250.39K$ -637.33K$ -581.22K$ -542.18K
Net Income Common Stockholders$ -1.19M$ -648.39K$ -1.11M$ -877.92K$ -832.27K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 12.55K$ 6.87K$ 64.55K$ 125.93K$ 49.80K
Total Assets$ 3.88M$ 3.99M$ 4.12M$ 4.29M$ 4.21M
Total Debt$ 5.54M$ 5.42M$ 5.18M$ 4.45M$ 3.85M
Net Debt$ 5.53M$ 5.42M$ 5.12M$ 4.33M$ 3.80M
Total Liabilities$ 17.70M$ 16.65M$ 16.14M$ 15.43M$ 14.62M
Stockholders Equity$ -13.81M$ -12.66M$ -12.01M$ -11.14M$ -10.41M
Cash Flow-
Free Cash Flow$ 5.68K$ -57.68K$ -661.38K$ -523.87K$ -395.02K
Operating Cash Flow$ 5.68K$ -57.68K$ -661.38K$ -523.87K$ -395.16K
Investing Cash Flow$ 0.00---$ 139.00
Financing Cash Flow$ 0.00$ 0.00$ 600.00K$ 600.00K$ 400.00K
Currency in USD

Calmare Therapeutics Earnings and Revenue History

Calmare Therapeutics Debt to Assets

Calmare Therapeutics Cash Flow

Calmare Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis